Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization

• Published in: Neuropsychiatric disease and treatment Vol. 15; pp. 2027 - 2034
• Main Authors: Mar, Javier, Arrospide, Arantzazu, Soto-Gordoa, Myriam, Iruin, Álvaro, Tainta, Mikel, Gabilondo, Andrea, Mar-Barrutia, Lore, Calvo, Montserrat, Mateos, Maider, Ibarrondo, Oliver
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.07.2019; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: Alzheimer's disease; antidepressant drugs; Antidepressants; Antipsychotic agents; antipsychotic drugs; Antipsychotics; Caregivers; Dementia; Dementia disorders; deprivation index; Diabetes; Drug therapy; Electronic medical records; Electronic records; Epidemiology; Equality; Gender; Gender equality; Hallucinogenic drugs; Health aspects; Health services; inequalities; Institutionalization; Medical records; Medical research; Mortality; Motor vehicle drivers; Neural coding; Neuropsychiatric symptoms; nursing home; Nursing homes; Original Research; Patients; prevalence; Primary care; Psychosis; Psychotropic drugs; Quality of life; Social class; Social environment; Socioeconomic factors; Statistical analysis; Tricyclic antidepressants; Variance analysis; Womens health; United Kingdom; Spain; prevalence; inequalities; antidepressant drugs; deprivation index; dementia; nursing home; neuropsychiatric symptoms; antipsychotic drugs

Dementia-related neuropsychiatric symptoms (NPS) are the main determinant of family stress and institutionalization of patients. This study aimed to identify inequalities by gender and socioeconomic status in the management of NPS in patients diagnosed with dementia. An observational study was carri...